Tom Fitzgerald is the founder of Transcode Therapeutics. Transcode Therapeutics has raised $45M in total funding. Latest round: Growth. Based in Boston, MA.
Tom Fitzgerald is a biotechnology executive who previously served as CEO of TransCode Therapeutics, a clinical-stage immuno-oncology company. In January 2024, he transitioned to Interim CEO and CFO. He has been instrumental in advancing the company's lead candidate, a microRNA-based therapy for metastatic solid cancers.
Full founder directory · Investor directory · Company funding database · Fundraising library